These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 11313005)

  • 21. Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.
    Kalla M; Hammerschmidt W
    Eur J Cell Biol; 2012 Jan; 91(1):65-9. PubMed ID: 21450364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Epstein-Barr virus infection - life cycle, methods of diagnosis, associated diseases].
    Bocian J; Januszkiewicz-Lewandowska D
    Postepy Hig Med Dosw (Online); 2011 May; 65():286-98. PubMed ID: 21677354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies.
    Westphal EM; Blackstock W; Feng W; Israel B; Kenney SC
    Cancer Res; 2000 Oct; 60(20):5781-8. PubMed ID: 11059774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactivation of Epstein-Barr virus from latency.
    Amon W; Farrell PJ
    Rev Med Virol; 2005; 15(3):149-56. PubMed ID: 15546128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Biology of the Epstein-Barr virus].
    Morand P; Seigneurin JM
    Ann Biol Clin (Paris); 1989; 47(7):421-7. PubMed ID: 2554764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative proteomic analysis implicates COMMD proteins as Epstein-Barr virus targets in the BL41 Burkitt's lymphoma cell line.
    Gkiafi Z; Panayotou G
    J Proteome Res; 2011 Jul; 10(7):2959-68. PubMed ID: 21615174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proof for EBV's sustaining role in Burkitt's lymphomas.
    Vereide D; Sugden B
    Semin Cancer Biol; 2009 Dec; 19(6):389-93. PubMed ID: 19628040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe Epstein-Barr virus infection in primary immunodeficiency and the normal host.
    Worth AJ; Houldcroft CJ; Booth C
    Br J Haematol; 2016 Nov; 175(4):559-576. PubMed ID: 27748521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human lymphotropic viruses associated with lymphoid malignancy: Epstein-Barr and HTLV-1.
    Ambinder RF
    Hematol Oncol Clin North Am; 1990 Aug; 4(4):821-33. PubMed ID: 2172203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS.
    Challine D; Buisson M; Cadilhac M; Germanidis G; Joab I; Eliaszewicz M; Caumes E; Flahault A; Fillet AM; Pawlotsky JM; Seigneurin JM
    J Med Virol; 2002 Aug; 67(4):510-5. PubMed ID: 12115996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus-associated lymphomas.
    Gandhi MK
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):77-89. PubMed ID: 16441211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus--associated diseases in humans.
    Kawa K
    Int J Hematol; 2000 Feb; 71(2):108-17. PubMed ID: 10745621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus-associated lymphoproliferative disorders.
    Ambinder RF
    Rev Clin Exp Hematol; 2003 Dec; 7(4):362-74. PubMed ID: 15129648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus and oncogenesis: from latent genes to tumours.
    Young LS; Murray PG
    Oncogene; 2003 Aug; 22(33):5108-21. PubMed ID: 12910248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oropharyngeal group A streptococcal colonization disrupts latent Epstein-Barr virus infection.
    Ueda S; Uchiyama S; Azzi T; Gysin C; Berger C; Bernasconi M; Harabuchi Y; Zinkernagel AS; Nadal D
    J Infect Dis; 2014 Jan; 209(2):255-64. PubMed ID: 23935199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases.
    Cohen JI
    Semin Hematol; 2003 Apr; 40(2):116-23. PubMed ID: 12704588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines.
    Perez-Chacon G; de Los Rios C; Zapata JM
    Pharmacol Res; 2014 Nov; 89():46-56. PubMed ID: 25180456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of Epstein-Barr virus in cancer.
    Pattle SB; Farrell PJ
    Expert Opin Biol Ther; 2006 Nov; 6(11):1193-205. PubMed ID: 17049016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.